BAY-299

Also Known As:

6-(3-hydroxypropyl)-2-(1,3,6-trimethyl-2-oxobenzimidazol-5-yl)benzo(de)isoquinoline-1,3-dione

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Triple Negative Breast Neoplasms 12/01/2023 - "Targeting TAF1 with BAY-299 induces antitumor immunity in triple-negative breast cancer."
2.	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/01/2021 - "TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia."